Monsey Medicaid costs for COVID-19 services totaled $8,311 in 2024

Monsey saw Medicaid payments reach $8,311 in 2024 for services coded to COVID-19, based on figures from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, a public health insurance initiative managed by the states and financed through a partnership between federal and state governments, serves low-income families and individuals, the elderly, children, and people living with disabilities. It is a major part of the U.S. health care framework.

Since Medicaid funding is taxpayer-based, local billing trends indicate how publicly funded health care dollars are distributed within a community.

This analysis determined COVID-19–related services using HCPCS codes marked or categorized as “COVID-19” or “coronavirus” in claim descriptions or reference information. As a result, service totals only include claims explicitly classified as COVID-related and may not reflect all pandemic-associated medical care billed under general medical codes.

For reference, Brooklyn had New York’s largest Medicaid spending on COVID-19 services in 2024, totaling $3,718,101 in related claims.

In Monsey, four separate providers filed Medicaid claims for COVID-19–related procedures in 2024. Immunoassay represented the most billed category, with $5,042 claimed under this code.

In terms of averages, Monsey’s per-provider Medicaid payment for COVID-19–related care was $2,078—well below the statewide figure of $29,403.

COVID-19–specific procedures accounted for a considerable portion of Monsey’s growing Medicaid expenditures throughout the pandemic years.

Across all other Medicaid claim types in Monsey, payments increased by $36,448,697 from 2020 through 2024, a 33.1% rise.

In the two years before the pandemic, annual Medicaid payments in Monsey averaged $82,271,681.

Centers for Medicare & Medicaid Services reports that federal and state Medicaid spending reached approximately $871.7 billion in fiscal year 2023, about 18% of all U.S. health expenditures, up from around $613.5 billion in 2019 before COVID-19 emerged.

This increase equals nearly 40% growth in just a few years, with much of that change driven by expanded enrollment and greater health care use during and after the pandemic period.

Federal budget measures enacted under the Trump administration have included proposals to cut back federal contributions to Medicaid and change its structure. The “One Big Beautiful Bill Act,” signed in 2025, is set to decrease federal Medicaid spending by more than $1 trillion over the coming decade and incorporates policies like new work requirements and increased cost-sharing that may reduce access and funding for part of the beneficiary population. These measures are expected to shift more Medicaid costs to states and temper federal support, despite the program’s ongoing role supporting millions of Americans.

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

All data for this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Access the underlying information here.